COMPANIES COVERED
TakedaDownload FREE Report Sample
Download Free sampleRECOMBINATE is?recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A.?
Plasma-derived Factor VIII Market contains market size and forecasts of Plasma-derived Factor VIII in global, including the following market information:
Global Plasma-derived Factor VIII Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Plasma-derived Factor VIII Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Plasma-derived Factor VIII companies in 2021 (%)
The global Plasma-derived Factor VIII market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
200IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Plasma-derived Factor VIII include Takeda, Octapharma, CSL, Grifols, Greencross, Kedrion, BPL, Hualan Bio and RAAS. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Plasma-derived Factor VIII manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Plasma-derived Factor VIII Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Plasma-derived Factor VIII Market Segment Percentages, by Type, 2021 (%)
200IU
250IU
Global Plasma-derived Factor VIII Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Plasma-derived Factor VIII Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Global Plasma-derived Factor VIII Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Plasma-derived Factor VIII Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Plasma-derived Factor VIII revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Plasma-derived Factor VIII revenues share in global market, 2021 (%)
Key companies Plasma-derived Factor VIII sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Plasma-derived Factor VIII sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Octapharma
CSL
Grifols
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
